Entera Bio (ENTX) Insider Trading & Ownership $1.55 -0.08 (-4.91%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Entera Bio (NASDAQ:ENTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage10.90%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$32,274.47Number OfInsiders Selling(Last 12 Months)0 Get ENTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Entera Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ENTX Insider Buying and Selling by Quarter Ad DarwinNew Year, New Opportunity! 2 AI Stocks Under $10 Ready to SoarAs we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.👉 Click here to access your FREE report now! Entera Bio Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/12/2024Haya TaitelDirectorBuy9,500$0.99$9,405.00 1/10/2024Haya TaitelDirectorBuy7,615$0.77$5,863.55 12/22/2023Miranda Jayne ToledanoCEOBuy23,952$0.71$17,005.92 (Data available from 1/1/2013 forward) ENTX Insider Trading Activity - Frequently Asked Questions Who is on Entera Bio's Insider Roster? The list of insiders at Entera Bio includes Haya Taitel, Miranda Jayne Toledano, Ramesh Ratan, Ron Mayron, Sean Ellis, and Yonatan Malca. Learn more on insiders at ENTX. What percentage of Entera Bio stock is owned by insiders? 10.90% of Entera Bio stock is owned by insiders. Learn more on ENTX's insider holdings. Which Entera Bio insiders have been buying company stock? The following insiders have purchased ENTX shares in the last 24 months: Haya Taitel ($15,268.55), Miranda Jayne Toledano ($47,305.92), and Sean Ellis ($24,000.00). How much insider buying is happening at Entera Bio? Insiders have purchased a total of 111,067 ENTX shares in the last 24 months for a total of $86,574.47 bought. Entera Bio Key ExecutivesMs. Miranda J. Toledano M.B.A. (Age 47)CEO & Director Compensation: $418kMs. Dana Yaacov-Garbeli CPA (Age 41)Chief Financial Officer Compensation: $193kDr. Hillel Galitzer M.B.A. (Age 46)Ph.D., Chief Operating Officer Compensation: $296kDr. Arthur C. Santora II (Age 73)M.D., Ph.D., Chief Medical Officer Compensation: $355k More Insider Trading Tools from MarketBeat Related Companies Trevi Therapeutics Insider Trading Biomea Fusion Insider Trading TScan Therapeutics Insider Trading Sutro Biopharma Insider Trading MacroGenics Insider Trading Zentalis Pharmaceuticals Insider Trading Inhibrx Insider Trading Zura Bio Insider Trading Editas Medicine Insider Trading Solid Biosciences Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ENTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
